financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Blue Owl Capital Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Blue Owl Capital Inc.
May 3, 2026 6:07 PM

12:35 PM EDT, 05/03/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We reduce our 12-month target price by $5 to $15, applying a more conservative equity risk premium and a forward P/E of 15.0x compared to the three-year historical average on 2026 earnings at 19.4x. We reduce our 2026 distributable earnings (DE) by $0.05 to $0.95 and 2027's by $0.10 to $1.05. We have seen negative investor sentiment on private credit, OWL's redemptions from retail investor, and direct loan exposure to technology and professional services businesses potentially hurt by AI disruption. However, fundamentals in private credit markets and specifically direct loans remain stable, with no signs of systemic risk or any indicators that loan delinquencies are accelerating. OWL has a diversified portfolio evident with direct loans representing only 37% of total AUM at $315B. In Q1 2026, fundraising rose to $44.4B Y/Y compared to $29.4B a year ago, and Private Credit was up $20.8B, +40% Y/Y (47% of total fundraising). Private Wealth fundraising was only $2.9B, mostly in Real Assets and Private Credit.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
May 11, 2026
10:10 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price is unchanged at $189, valuing shares at 19.2x our next-12-month EPS estimate of $9.86, slightly below IPP peers averaging 19.5x but significantly above NRG's highly volatile...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
May 11, 2026
09:15 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target to $84 from $98, based on 16.9x our 2027 EPS estimate, below GMED's five-year average forward P/E multiple. We raise our 2026 EPS view to $4.72...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
May 11, 2026
07:20 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $42, raised $2, reflects relative valuation and our DCF models. On a relative basis, we apply a 4.5x multiple of enterprise value to projected 2027...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
May 11, 2026
08:00 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $43 to $229, valuing ALB at 27.1x on our 2027 EPS estimate, a premium to ALB's normalized average fwd P/E during the last...
Copyright 2023-2026 - www.financetom.com All Rights Reserved